Pricing Log in Create free account

Achieve Life Sciences, Inc. (ACHV) vs Design Therapeutics, Inc. (DSGN)

Achieve Life Sciences, Inc. and Design Therapeutics, Inc. are both Biotechnology companies. Achieve Life Sciences, Inc. and Design Therapeutics, Inc. are of similar size ($682.0M and $658.6M). Across the 10 metrics below, Achieve Life Sciences, Inc. leads on 6 and Design Therapeutics, Inc. on 4.

Valuation

Metric ACHV DSGN Biotechnology median
P/E n/m n/m 10.96
P/S 40.07 2,987.24 9.52
P/B n/m 3.34 2.23
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 0.68
EV/Sales 29.26 2,064.19 9.00
Earnings yield (22.86%) (11.22%) (32.09%)
Free cash flow yield (7.42%) (8.79%) (22.62%)

Profitability

Metric ACHV DSGN Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (844.99%) (36.87%) (50.12%)
Return on assets (91.46%) (34.57%) (45.12%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ACHV DSGN Biotechnology median
Revenue growth (TTM) (5.58%) — 6.78%
EPS growth (last fiscal year) (0.81%) (38.64%) 29.88%
Revenue growth, 5-year CAGR (17.95%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACHV DSGN Biotechnology median
Debt to equity (1.11) 0.00 0.00
Current ratio 0.95 16.78 4.74
Net debt to EBITDA 0.36 2.68 1.01

Dividend

Metric ACHV DSGN Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric ACHV DSGN Biotechnology median
Market cap 658.58m 681.98m 166.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack